Fierce Pharma

JANUARY 19, 2024

A jury has found a former Pfizer statistician guilty of insider trading after a two-week trial in federal court in the Southern District of New York. | A federal jury has found a former Pfizer statistician guilty of insider trading after a two-week trial in Manhattan. The jury convicted Amit Dagar, 44, of Hillsborough, N.J., of using advance information on successful trial results for Pfizer’s COVID-19 treatment Paxlovid to make more than $270,000 in stock trades.

362

362

MedCity News

JANUARY 19, 2024

The former Pfizer statistician worked on the clinical trial for the Covid-19 drug Paxlovid. A jury found the employee guilty of insider trading for transactions made before clinical data for the antiviral were publicly announced.

Biopharma 145

Biopharma Pharma 145

Fierce Pharma

JANUARY 19, 2024

Following public spats with Hungary and Poland, Pfizer and its German mRNA partner BioNTech have kicked off legal proceedings against Romania. | Following public spats with Hungary and Poland, Pfizer and its German mRNA partner BioNTech have kicked off legal proceedings against Romania. The lawsuit marks the latest move in Pfizer’s campaign to press countries to honor COVID-19 vaccine contracts inked by the European Commission in May 2021.

321

321

MedCity News

JANUARY 19, 2024

AI, health equity and merger and acquisition activity are among the trends to watch in 2024, according to a recent report from Deloitte.

Healthcare 140

Healthcare Healthcare 140

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

Fierce Pharma

JANUARY 19, 2024

More than five years after an FDA accelerated approval in a subtype of progressive colorectal cancer, Bristol Myers Squibb now has data supporting its checkpoint inhibitor doublet in newly diagnose | More than five years after an FDA accelerated approval in a subtype of progressive colorectal cancer, Bristol Myers Squibb now has data supporting its checkpoint inhibitor doublet in newly diagnosed patients.

FDA 321

FDA Patients 321

MedCity News

JANUARY 19, 2024

By adopting integrated care models, providers and payors can ensure a seamless continuum of care for older adults.

Physicians 124

Physicians 124

MedCity News

JANUARY 19, 2024

Innovation in the HIV treatment landscape is playing a role in addressing medication adherence. In recent years, long-acting injectable antiretroviral monthly and bi-monthly treatment options have been approved – a welcome alternative for people living with HIV.

Medical 122

Medical Patients Biopharma 122

Fierce Pharma

JANUARY 19, 2024

Use of Amgen’s osteoporosis drug Prolia by those with advanced chronic kidney disease (CKD) can increase the risk of calcium loss in the blood, according to the FDA. | Use of Amgen’s osteoporosis drug Prolia by those with advanced chronic kidney disease (CKD) can increase the risk of calcium loss in the blood, according to the FDA. The U.S. regulator has added a boxed warning for the blockbuster treatment, which has been on the market for 14 years and loses patent protection next year.

FDA 214

FDA Marketing 214

MedCity News

JANUARY 19, 2024

The psychiatric collaborative care model offers an opportunity to mitigate burnout by reducing the burden placed on primary care providers (PCPs) and more effectively supporting their patients with behavioral health needs.

Patients 120

Patients Physicians 120

Fierce Pharma

JANUARY 19, 2024

Injectable formulations are the fastest growing segment in the pharmaceutical industry. According to Precedence Research, the global injectable drug delivery market reached U.S. | Simplifying the administration of complex injectables for reconstitution, liquid/liquid mixing and the sequential delivery of multiple liquid drugs.

Medical 130

Medical Pharmaceutical Marketing 130

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

pharmaphorum

JANUARY 19, 2024

AstraZeneca gets its first approval for oral Factor D inhibitor danicopan, in Japan, for treatment of paroxysmal nocturnal haemoglobinuria

116

116

MedCity News

JANUARY 19, 2024

Hospitals weathered one of their most challenging years in 2022, with median operating margins staying in the red throughout most of the year. Those money problems proved to be a major factor shaping last year’s M&A transactions — financial pressures influenced 28% of hospital M&A deals last year, up from 15% in 2022, a new report showed.

110

110

pharmaphorum

JANUARY 19, 2024

CG Oncology joins the queue of US biotech companies hoping to complete an IPO, aiming to raise $181m for its late-stage bladder cancer therapy.

111

111

Pharmaceutical Commerce

JANUARY 19, 2024

Experts explore ways in which the financial sector refined the healthcare landscape, including its evolutions throughout the years.

Healthcare 100

Healthcare Healthcare 100

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

pharmaphorum

JANUARY 19, 2024

Manufacturing problems have scuppered Satsuma Pharmaceuticals’ chances of a timely FDA approval for its intranasal migraine therapy STS101. The drug – a new dry powder intranasal formulation of the well-established migraine therapy dihydroergotamine mesylate (DHE) – was submitted for approval in the US last March as an easy-to-use, portable treatment option for acute migraine attacks, with or without aura, in adult patients.

FDA 105

FDA Manufacturing Pharmaceutical Patients 105

PharmaTimes

JANUARY 19, 2024

New stroke therapy delivers electrical pulses to the brain

100

100

European Pharmaceutical Review

JANUARY 19, 2024

According to GlobalData, with demonstrated efficacy against carbapenem-resistant Acinetobacter Baumanni (CRAB), Roche’s zosurabalpin “has the potential to treat lethal hospital infection,” Anaelle Tannen, Infectious Disease Analyst at GlobalData explained. Currently in Phase I development , the antibiotic’s novel mechanism of action was showcased through its effectiveness against the pathogen in in vitro studies.

Manufacturing 98

Manufacturing Medicine Leads Pharmaceutical 98

PharmaTimes

JANUARY 19, 2024

Company will present vital findings at SRI annual meeting

99

99

Advertisement

Pharmaceutical Technology

JANUARY 19, 2024

BridgeBio Pharma has secured strategic financing of $1.25bn from Blue Owl Capital and CPP Investments for genetic therapies.

Pharma 98

Pharma 98

European Pharmaceutical Review

JANUARY 19, 2024

The National Institute for Health and Care Excellence (NICE) has published final draft guidance recommending Pfizer’s TALZENNA ® (talazoparib) for HER2- negative, locally advanced or metastatic breast cancer with germline BRCA1 or BRCA2 mutations. An important advance in treating breast cancer The pharmaceutical company shared that its oral small molecule poly (ADP-ribose) polymerase (PARP) inhibitor is indicated in adults who have had an anthracycline or a taxane, or both, if suitable,

Pharmacology 98

Pharmacology Patients Pharmaceutical Medicine 98

Referral MD

JANUARY 19, 2024

How do healthcare providers benefit from patient engagement tools and other healthcare software solutions? Patient-centric care is more critical than ever in today’s fast-paced healthcare landscape. Healthcare providers must deliver high-quality medical services and engage with patients effectively and efficiently. Patient engagement, referral management, and Customer Relationship Management (CRM) software have become powerful tools to achieve these goals.

Management 94

Management Patients CRM Customer Relationship Management 94

Pharmaceutical Commerce

JANUARY 19, 2024

All healthcare stakeholders must participate to dismantle barriers and ensure access to medicines that save lives.

Medicine 80

Medicine Patients Healthcare Healthcare 80

Advertisement

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

Sales

Pharmaceutical Technology

JANUARY 19, 2024

The layoffs will free cash resources that will extend financial runways and focus pipeline developmental efforts.

Pharma 69

Pharma 69

Pharmacy Times

JANUARY 19, 2024

Benzodiazepines have proven effective in managing anxiety and insomnia, but they heighten risk of falls, cognitive impairment, functional decline, and mortality among older adults.

Management 62

Management 62

Clarivate

JANUARY 19, 2024

Planning for the year ahead in the intellectual property (IP) space is increasingly challenging. While the unknowns of AI are top of mind, there are many variables in the IP legal industry projected to influence 2024. Practitioners can expect to see more integrations and toolsets that combine previously separate workflows; China will continue to influence the IP and innovation landscape; litigation is predicted to rise with the increase of infringing products; and new jurisdictions, such as the

Management 59

Management Consulting Professional Services Sales 59

Pharmacy Times

JANUARY 19, 2024

The third edition of the Pharmacy Quality Alliance resource guide includes 40 total SDOH services and 8 new services, as well as 10 initiative updates from the previous 2 editions.

59

59

Advertisement

Distribution

Pharmaceutical Technology

JANUARY 19, 2024

Japan has approved argenx’s VYVDURA injection for subcutaneous administration to treat generalised myasthenia gravis (gMG) in adults.

59

59

Pharmacy Times

JANUARY 19, 2024

Compared to placebo, a daily multivitamin showed consistent benefits in global cognition and episodic memory across a clinical trial and meta-analysis of 3 trials.

55

55

Referral MD

JANUARY 19, 2024

Accurate information for personalized, value based care In a world where value-based care is prioritized, healthcare providers ACOs, FQHCs, Healthcare Systems, and Hospitals must comprehensively understand a patient’s health to effectively manage costs, mitigate risks, and deliver high-quality, personalized care. A key aspect of achieving these goals is ensuring that the patient’s health conditions are accurately and wholly coded, as this plays a crucial role in determining appropria

Healthcare Provider 52

Healthcare Provider Healthcare Healthcare Management 52

Pharmacy Times

JANUARY 19, 2024

In 2024, there is an urgent need for policies that will accelerate biosimilar use to achieve lower system-wide health care costs.

52

52

Advertisement

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A

Sales